Traditional Chinese medicinal decoction for treating acute gouty arthritis

Abstract

The invention discloses a traditional Chinese medicinal decoction for treating acute gouty arthritis. The decoction is prepared from the following raw medicinal materials in parts by weight: 30 parts of felwort, 30 parts of purslane, 20 parts of ash bark, 15 parts of stramonium, 25 parts of calamus, 20 parts of honeysuckle, 20 parts of cortex erythrinae, 15 parts of rhizoma arisaematis, 10 parts of bamboo leaf, 15 parts of radix berberidis, 20 parts of tinospora sinensis merr, 25 parts of gallnut, 10 parts of coptis chinensis, 25 parts of erycibe obtusifolia benth, 20 parts of herba houttuyniae, 8 parts of polygonatum kingianum, 22 parts of salviae miltiorrhizae, 10 parts of fructus psoraleae, 15 parts of ligusticum wallichii, 5 parts of cinnamon, 12 parts of rhizoma atractylodis macrocephalae, 16 parts of frankincense, 20 parts of unpleasant swallowwort herb, 15 parts of couch grass root and 10 parts of liquorice. The raw medicinal materials are compatible by syndrome differentiation to play the roles in dispelling wind and eliminating humidity, clearing heat and removing toxicity, eliminating cold to stop pain, tonifying spleen and kidney, can be used for effectively relieving the symptom of a patient with acute gouty arthritis and reducing the content of blood uric acid in a human body, has a remarkable curative effect on the acute gouty arthritis, is safe, and does not have toxic or side effect.

Description

technical field [0001] The invention relates to a traditional Chinese medicine decoction for treating acute gouty arthritis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Acute gouty arthritis is a common and frequently-occurring disease that seriously endangers human health. It is a group of diseases caused by purine metabolism disorder and (or) decreased uric acid excretion. The clinical features are hyperuricemia, recurrent acute monoarthritis, tophi deposits formed by sodium urate salt, tophi, etc., and with the improvement of living standards, the incidence rate tends to increase gradually, and the complications of the disease Severe, long medical history, high treatment costs. [0003] At present, the treatment of acute gouty arthritis generally uses colchicine, non-steroidal anti-inflammatory drugs and glucocorticoids, etc., but there are the following defects: ① the application of colchicine, although it has a good analg...

AI Technical Summary

Problems solved by technology

The clinical features are hyperuricemia, recurrent acute monoarthritis, tophi deposits formed by sodium urate salt, tophi, etc., and with the improvement of living standards, the incidence rate tends to increase gradually, and the complications of the disease Severe, long medical history, high treatment costs

[0003] At present, the treatment of acute gouty arthritis generally uses colchicine, non-steroidal anti-inflammatory drugs and glucocorticoids, etc., but there are the following defects: ① the application of colchicine, although it has a good analgesic effect, but the drug Very toxic, such as nausea and vomiting, abdominal pain and diarrhea, liver cell damage, bone marrow suppression, hair loss, respiratory depression, etc.